# Indaptus Therapeutics, Inc.: filings

INDP · Nasdaq · CIK 1857044 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/indp.md) · [Financials](/companies/indp/financials.md) · [Filings](/companies/indp/filings.md) · [Insiders](/companies/indp/insiders.md)

## Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 84, 8-K 74, 3 24, 10-Q 17, EFFECT 15, SCHEDULE 13D/A 12, CORRESP 10, UPLOAD 10, 424B5 8, S-3 8, DEF 14A 7, POS AM 6, S-1 6, 10-K 5, D 5, DEFA14A 5, SC 13D/A 5, 424B3 4, 425 4, PRE 14A 4, S-8 4, SC 13D 4, 8-K/A 3, SC 13G/A 3, AW 2, RW 2, SCHEDULE 13D 2, 8-A12B 1, ARS 1, CERT 1, D/A 1, DRS 1, S-1/A 1, S-4 1, S-4/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:06 ET | [SCHEDULE 13D/A](/filings/0001829126-26-011445.md) | Ownership report, active investor, amended | 0001829126-26-011445 |
| 2026-10-22 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001829126-26-011444.md) | Ownership report, active investor, amended | 0001829126-26-011444 |
| 2026-10-22 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001829126-26-011443.md) | Ownership report, active investor, amended | 0001829126-26-011443 |
| 2026-10-21 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001829126-26-011386.md) | Ownership report, active investor, amended | 0001829126-26-011386 |
| 2026-10-20 | 20:38 ET | [8-K](/filings/0001493152-26-047770.md) | 8.01 Other events | 0001493152-26-047770 |
| 2026-09-30 | 13:05 ET | [8-K](/filings/0001493152-26-045040.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-045040 |
| 2026-09-10 | 01:45 ET | [8-K](/filings/0001493152-26-042037.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042037 |
| 2026-09-08 | 01:55 ET | [8-K/A](/filings/0001493152-26-041636.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041636 |
| 2026-09-04 | 20:05 ET | [8-K](/filings/0001493152-26-041532.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041532 |
| 2026-09-01 | 11:30 ET | [8-K](/filings/0001493152-26-040926.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-040926 |
| 2026-08-13 | 11:35 ET | [10-Q](/filings/0001493152-26-037579.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037579 |
| 2026-08-13 | 11:30 ET | [8-K](/filings/0001493152-26-037574.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-037574 |
| 2026-07-16 | 20:35 ET | [DEF 14A](/filings/0001493152-26-033545.md) | Proxy statement, period 2026-07-16 | 0001493152-26-033545 |
| 2026-06-26 | 01:40 ET | [SCHEDULE 13D/A](/filings/0001829126-26-006953.md) | Ownership report, active investor, amended | 0001829126-26-006953 |
| 2026-06-26 | 00:00 ET | [SCHEDULE 13D/A](/filings/0001829126-26-006951.md) | Ownership report, active investor, amended | 0001829126-26-006951 |
| 2026-06-26 | 00:00 ET | [SCHEDULE 13D/A](/filings/0001829126-26-006950.md) | Ownership report, active investor, amended | 0001829126-26-006950 |
| 2026-06-26 | 00:00 ET | [SCHEDULE 13D/A](/filings/0001829126-26-006949.md) | Ownership report, active investor, amended | 0001829126-26-006949 |
| 2026-06-24 | 20:01 ET | [8-K](/filings/0001493152-26-029918.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-029918 |
| 2026-06-05 | 20:30 ET | [8-K](/filings/0001493152-26-027499.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027499 |
| 2026-05-15 | 12:15 ET | [10-Q](/filings/0001493152-26-023362.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023362 |
| 2026-05-15 | 12:00 ET | [8-K](/filings/0001493152-26-023344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023344 |
| 2026-04-29 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001829126-26-004104.md) | Ownership report, active investor, amended | 0001829126-26-004104 |
| 2026-04-24 | 21:00 ET | [8-K/A](/filings/0001493152-26-018954.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-018954 |
| 2026-04-23 | 01:59 ET | [8-K](/filings/0001493152-26-018608.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-018608 |
| 2026-04-03 | 16:00 ET | [8-K](/filings/0001493152-26-015079.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-015079 |
| 2026-03-30 | 01:46 ET | [SCHEDULE 13D](/filings/0001829126-26-002858.md) | Ownership report, active investor | 0001829126-26-002858 |
| 2026-03-24 | 20:30 ET | [8-K](/filings/0001493152-26-012372.md) | 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-012372 |
| 2026-03-24 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001829126-26-002642.md) | Ownership report, active investor, amended | 0001829126-26-002642 |
| 2026-03-17 | 20:30 ET | [10-K](/filings/0001493152-26-010585.md) | Annual report, period 2025-12-31 | 0001493152-26-010585 |
| 2026-03-02 | 22:20 ET | [SCHEDULE 13D](/filings/0001829126-26-001810.md) | Ownership report, active investor | 0001829126-26-001810 |
| 2026-02-27 | 21:05 ET | [8-K](/filings/0001493152-26-008326.md) | 3.03 Change to security holders’ rights; 5.01 Change in control; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-008326 |
| 2026-02-12 | 14:30 ET | [8-K](/filings/0001493152-26-006330.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-006330 |
| 2026-01-21 | 22:21 ET | [DEF 14A](/filings/0001493152-26-003135.md) | Proxy statement, period 2026-01-21 | 0001493152-26-003135 |
| 2026-01-20 | 21:06 ET | [8-K](/filings/0001493152-26-002850.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-002850 |
| 2026-01-08 | 22:26 ET | [8-K](/filings/0001493152-26-001004.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-001004 |
| 2026-01-02 | 21:05 ET | [8-K](/filings/0001493152-26-000106.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-000106 |
| 2025-12-30 | 21:01 ET | [SCHEDULE 13D/A](/filings/0001493152-25-029593.md) | Ownership report, active investor, amended | 0001493152-25-029593 |
| 2025-12-30 | 21:01 ET | [SCHEDULE 13D/A](/filings/0001493152-25-029594.md) | Ownership report, active investor, amended | 0001493152-25-029594 |
| 2025-12-23 | 22:22 ET | [8-K](/filings/0001493152-25-029107.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-029107 |
| 2025-11-12 | 13:31 ET | [10-Q](/filings/0001493152-25-021759.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021759 |
| 2025-11-12 | 13:30 ET | [8-K](/filings/0001493152-25-021758.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021758 |
| 2025-09-04 | 20:01 ET | [8-K](/filings/0001493152-25-012630.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012630 |
| 2025-09-03 | 17:27 ET | [S-1/A](/filings/0001641172-25-026333.md) | Registration statement, amended | 0001641172-25-026333 |
| 2025-09-02 | 13:15 ET | [S-1](/filings/0001493152-25-012531.md) | Registration statement | 0001493152-25-012531 |
| 2025-08-13 | 12:01 ET | [10-Q](/filings/0001641172-25-023333.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023333 |
| 2025-08-13 | 12:00 ET | [8-K](/filings/0001641172-25-023332.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023332 |
| 2025-07-29 | 20:15 ET | [8-K](/filings/0001641172-25-021377.md) | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001641172-25-021377 |
| 2025-07-16 | 20:15 ET | [8-K](/filings/0001641172-25-019893.md) | 8.01 Other events | 0001641172-25-019893 |
| 2025-07-01 | 12:38 ET | [8-K](/filings/0001641172-25-017283.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017283 |
| 2025-06-26 | 21:15 ET | [8-K](/filings/0001641172-25-016694.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016694 |

Page 1 of 3. [Older](/companies/indp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.